Toxicity List of articles

ELIQUENT Japan > Toxicity

2026.10.09

White,medical,pills,and,tablets,spilling,out,of,a,drug

Early Consideration on General Toxicity Evaluation of Monoclonal Antibodies in Japan

Introduction to General Toxicity Evaluation of Monoclonal Antibodies On May 13, 2026, the Pharmaceuticals and […]

COMPANY

Company Name: Eliquent Japan, Inc.
Location: Shinjuku i-Land Tower 41F, 6-5-1 Nishi Shinjuku, Shinjuku-ku 163-1341 Tokyo, Japan
Representative Director, CEO: Shunsuke Iwano
Business Scope: Regulatory Consulting
 Phone:+81-3-6304-5570